IBA (Ion Beam Applications S.A., EURONEXT), the world leader in particle accelerator technology and the world’s leading provider of proton therapy solutions for the treatment of cancer, is pleased to ...

As Lexy Thornberry fights her battle against head and neck cancer, her fiancee and professional boxer David Nyika dedicated ...

Every year in biopharma brings its share of grueling defeats, and 2025 was no different, especially for companies targeting ...

An immunomodulatory vaccine advancing to phase 3 trials highlights the evolving role of immune system recalibration in cancer treatment. From immunotherapy breakthroughs to early-stage scientific ...

Can the immune system cure cancer? Dr. Patrick Soon-Shiong discusses a paradigm shift using NK cells to treat tumors without ...

Adolescents and young adults with stage IV cancer have unique primary tumor sources and survive longer with synchronous brain metastases than older adults.

Melanoma located on the head and neck was associated with higher risk of all-cause and cancer-specific mortality compared with tumors on the trunk.

In the 21st century, oncology has achieved extraordinary progress. We can decode a tumor’s genome, tailor therapies to ...

A new study published today in The Lancet showed a significant survival benefit for patients with oropharyngeal cancers who ...

A study published in The Lancet showed a significant survival benefit for patients with oropharyngeal cancers who were ...

Media seeking NAPT materials can access assets here.

Data demonstrates the significant and sustained tumor regression achieved by the CAPTN-3 platform across two distinct ...